Furthermore, protein IP assays demonstrated that PHF23 interacts with ACTN4 in the cell plasma, suggesting that PHF23 in the cytoplasm interacts with ACTN4 to activate the ERK signaling pathway and promote the malignant phenotype of NSCLC cells (Fig. 5D, E). The gene discussed is PHF23; the disease is non-small cell lung carcinoma.